You are here: Home > Over-the-counter (OTC) Drugs > N > Noevir 5 Treatment Liquid Foundation Lx (Noevir Usa Inc)

Name:Noevir 5 Treatment Liquid Foundation Lx
Manufacturer:Noevir Usa Inc
Category:Over-the-counter (OTC) Marketed Drugs


Drug Facts

NOEVIR 5 TREATMENT LIQUID FOUNDATION LX  - octinoxate and titanium dioxide liquid 
NOEVIR USA INC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Drug Facts

Drug Facts

Drug Facts
Active Ingredients                       Purpose
OCTINOXATE  1%                   Sunscreen
TITANIUM DIOXIDE 7.49%         Sunscreen

Uses
  • Helps prevent sunburn.
  • Higher SPF gives more sunburn protection.
  • Provides high protection against sunburn.
Warnings
For external use only.
When using this product
  • Keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if
  • Rash or irritation develops and lasts.
Keep out of reach of children
  • If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Apply a thin, even layer. For full coverage, apply additional layers.
  • Apply evenly before sun exposure.
  • Children under 6 months of age ask a doctor.
  • Reapply as needed or after towel drying, swimming or sweating.

tube image

box image
box image



NOEVIR 5 TREATMENT LIQUID FOUNDATION LX 
octinoxate, titanium dioxide liquid
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:62908-013
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OCTINOXATE (OCTINOXATE) OCTINOXATE 1000 mg  in 100 g
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE 7490 mg  in 100 g
Product Characteristics
Color      Score     
Shape Size
Flavor Imprint Code
Contains     
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:62908-013-02 1 TUBE ( TUBE) in 1 BOX contains a TUBE (62908-013-01)
1 NDC:62908-013-01 38 g in 1 TUBE This package is contained within the BOX (62908-013-02)

Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 08/01/2010

Labeler - NOEVIR USA INC (018593293)
Registrant - NOEVIR USA INC (018593293)
Establishment
Name Address ID/FEI Operations
NOEVIR CO Ltd 690620521 manufacture

Revised: 08/2010 NOEVIR USA INC



Source: http://dailymed.nlm.nih.gov
Reproduced with permission of U.S. National Library of Medicine


Copyright © 2019 Drugsdb.eu by Dionisios Fentas || Terms of Use

Loading

OTC Marketed Drugs Alphabetically
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z| 0-9

Categories:
Prescription(RX) Drugs
Over-the-counter (OTC) Drugs
Homeopathic Drugs
Animal Drugs
Feedback